Origin and extraction
Hematopoietic stem cells are isolated from the residual blood in the newborn’s umbilical cord—a painless and completely safe process for both mother and infant. Novacell collects these cells using sterile equipment and in accordance with international standards, followed by storage under strictly controlled conditions.
Cellular properties and function
These stem cells can differentiate into the three major blood cell lineages:
- Red blood cells (erythrocytes)
- White blood cells (leukocytes)
- Platelets (thrombocytes)
In the body, they play a critical role in bone marrow reconstitution and immune system recovery and have been used clinically in the treatment of more than 80 blood‑related diseases.
Storage and maintenance technology
At Novacell, freezing and long‑term storage are performed using multi‑stage cryogenic systems, ensuring that cells remain viable, functional, and stable for many years without loss of quality.
Therapeutic applications
Umbilical cord blood hematopoietic stem cells are used in the treatment of leukemia, lymphoma, congenital anemias, immune deficiencies, and bone marrow recovery following chemotherapy. They are also being increasingly explored in research projects targeting metabolic and neurological diseases.
